Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.

Bar-Or A, Grove RA, Austin DJ, Tolson JM, VanMeter SA, Lewis EW, Derosier FJ, Lopez MC, Kavanagh ST, Miller AE, Sorensen PS.

Neurology. 2018 May 15;90(20):e1805-e1814. doi: 10.1212/WNL.0000000000005516. Epub 2018 Apr 25.

2.

A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors.

Mateo J, Ganji G, Lemech C, Burris HA, Han SW, Swales K, Decordova S, DeYoung MP, Smith DA, Kalyana-Sundaram S, Wu J, Motwani M, Kumar R, Tolson JM, Rha SY, Chung HC, Eder JP, Sharma S, Bang YJ, Infante JR, Yan L, de Bono JS, Arkenau HT.

Clin Cancer Res. 2017 Oct 1;23(19):5981-5992. doi: 10.1158/1078-0432.CCR-17-0725. Epub 2017 Jun 23.

PMID:
28645941
3.

A 52-week study of gabapentin enacarbil in restless legs syndrome.

Ellenbogen AL, Thein SG, Winslow DH, Becker PM, Tolson JM, Lassauzet ML, Chen D.

Clin Neuropharmacol. 2011 Jan-Feb;34(1):8-16. doi: 10.1097/WNF.0b013e3182087d48.

PMID:
21242741
4.

Patient- and physician-rated measures demonstrate the effectiveness of ropinirole in the treatment of restless legs syndrome.

Kushida CA, Geyer J, Tolson JM, Asgharian A.

Clin Neuropharmacol. 2008 Sep-Oct;31(5):281-6. doi: 10.1097/WNF.0b013e31815a3eec.

PMID:
18836346
5.

Recognition, diagnosis, and treatment of restless legs syndrome.

Smith JE, Tolson JM.

J Am Acad Nurse Pract. 2008 Aug;20(8):396-401. doi: 10.1111/j.1745-7599.2008.00337.x. Review.

PMID:
18786013
6.

Impact of an educational program on efficacy and adherence with a twice-daily lamivudine/zidovudine/abacavir regimen in underrepresented HIV-infected patients.

Rawlings MK, Thompson MA, Farthing CF, Brown LS, Racine J, Scott RC, Crawford KH, Goodwin SD, Tolson JM, Williams VC, Shaefer MS; NZTA4006 Helping to Enhance Adherence to Antiretroviral Therapy (HEART) Study Team.

J Acquir Immune Defic Syndr. 2003 Oct 1;34(2):174-83.

PMID:
14526206
7.

Once-daily quadruple-drug therapy with adefovir dipivoxil, Lamivudine, Didanosine, and efavirenz in treatment-naive human immunodeficiency virus type 1-infected patients.

Skowron G, Kuritzkes DR, Thompson MA, Squires KE, Goodwin SD, Dusak BA, Tolson JM, Stevens M, Yuen GJ, Rooney JF; Intercompany Collaboration for AIDS Drug Development Protocol 604 Team.

J Infect Dis. 2002 Oct 1;186(7):1028-33. Epub 2002 Sep 13. Erratum in: J Infect Dis 2002 Dec 15;186(12):1872.

PMID:
12232846
8.

Immunologic and virologic consequences of temporary antiretroviral treatment interruption in clinical practice.

Chen RY, Westfall AO, Raper JL, Cloud GA, Chatham AK, Acosta EP, Pham SV, Tolson JM, Heudebert GR, Saag MS.

AIDS Res Hum Retroviruses. 2002 Sep 1;18(13):909-16.

PMID:
12230934
9.

Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome.

DeMasi RA, Graham NM, Tolson JM, Pham SV, Capuano GA, Fisher RL, Shaefer MS, Pakes GE, Sawyerr GA, Eron JJ Jr.

Adv Ther. 2001 Jul-Aug;18(4):163-73.

PMID:
11697019
10.

Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infection.

Call SA, Saag MS, Westfall AO, Raper JL, Pham SV, Tolson JM, Hellmann NS, Cloud GA, Johnson VA.

J Infect Dis. 2001 Feb 1;183(3):401-8. Epub 2000 Dec 29.

PMID:
11133371
11.

Impact of zidovudine-based triple combination therapy on an AIDS drug assistance program.

Mauskopf JA, Tolson JM, Simpson KN, Pham SV, Albright J.

J Acquir Immune Defic Syndr. 2000 Apr 1;23(4):302-13.

PMID:
10836752
12.

Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection.

Eron JJ, Yetzer ES, Ruane PJ, Becker S, Sawyer GA, Fisher RL, Tolson JM, Shaefer MS.

AIDS. 2000 Apr 14;14(6):671-81. Erratum in: AIDS 2000 Jun 16;14(9):1295.

PMID:
10807190

Supplemental Content

Loading ...
Support Center